Skip to main content

Peer Review reports

From: Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice

Original Submission
23 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
21 Jun 2023 Reviewed Reviewer Report - Manavi D Sindal
22 Sep 2023 Author responded Author comments - Ehsan Rahimy
Resubmission - Version 5
22 Sep 2023 Submitted Manuscript version 5
26 Sep 2023 Author responded Author comments - Ehsan Rahimy
Resubmission - Version 6
26 Sep 2023 Submitted Manuscript version 6
2 Oct 2023 Author responded Author comments - Ehsan Rahimy
Resubmission - Version 7
2 Oct 2023 Submitted Manuscript version 7
10 Oct 2023 Author responded Author comments - Ehsan Rahimy
Resubmission - Version 8
10 Oct 2023 Submitted Manuscript version 8
25 Oct 2023 Reviewed Reviewer Report - Manavi D Sindal
21 Jan 2024 Reviewed Reviewer Report
12 Apr 2024 Author responded Author comments - Ehsan Rahimy
Resubmission - Version 9
12 Apr 2024 Submitted Manuscript version 9
25 Apr 2024 Reviewed Reviewer Report
20 May 2024 Author responded Author comments - Ehsan Rahimy
Resubmission - Version 10
20 May 2024 Submitted Manuscript version 10
Publishing
23 May 2024 Editorially accepted
31 May 2024 Article published 10.1186/s12886-024-03491-w

You can find further information about peer review here.

Back to article page